Citation: De. Wedge et Nd. Camper, Connections between agrochemicals and pharmaceuticals, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 1-15
Authors:
Kinghorn, AD
Cui, BL
Ito, A
Chung, HS
Seo, EK
Long, L
Chang, LC
Citation: Ad. Kinghorn et al., Fractionation of plants to discover substances to combat cancer, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 17-24
Citation: Js. Miller et Re. Gereau, Therapeutic potential of plant-derived compounds: Realizing the potential, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 25-37
Authors:
Kingston, DGI
Abdel-Kader, M
Zhou, BN
Yang, SW
Berger, JM
van der Werff, H
Evans, R
Mittermeier, R
Malone, S
Famolare, L
Guerin-McManus, M
Wisse, JH
Miller, JS
Citation: Dgi. Kingston et al., Biodiversity conservation, economic development, and drug discovery in Suriname, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 39-59
Citation: G. Majetich, Recent trends in the use of natural products and their derivatives as potential pharmaceutical agents, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 61-71
Citation: Kh. Lee, Highlights of research on plant-derived natural products and their analogswith antitumor, anti-HIV, and antifungal activity, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 73-94
Citation: Am. Clark et La. Walker, Discovery of antifungal agents from natural sources: Virulence factor targets, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 95-107
Citation: Ra. Hudson et Lmv. Tillekeratne, Reactive quinones: From chemical defense mechanisms in plants to drug design, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 109-119
Citation: Ma. Avery et al., Structure-activity relationships of peroxide-based artemisinin antimalarials, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 121-132
Authors:
Mitscher, LA
Pillai, SP
Menon, SR
Pillai, CA
Shankel, DM
Citation: La. Mitscher et al., Naturally occurring antimutagenic and cytoprotective agents, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 133-150
Citation: Cr. Mccurdy et al., Lobeline: A natural product with high affinity for neuronal nicotinic receptors and a vast potential for use in neurological disorders, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 151-162
Citation: At. Sneden, Protein kinase C inhibitory phenylpropanoid glycosides from Polygonum species, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 163-171
Authors:
Johnson, HA
Oberlies, NH
Alali, FQ
McLaughlin, JL
Citation: Ha. Johnson et al., Thwarting resistance: Annonaceous acetogenins as new pesticidal and antitumor agents, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 173-183
Citation: Ka. Alvi, A strategy for rapid identification of novel therapeutic leads from natural products, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 185-195
Citation: Jk. Buolamwini et F. Ali-osman, Dynamic docking study of the binding of 1-chloro-2,4-dinitrobenzene in theputative electrophile binding site of naturally occurring human glutathione S-transferase pi allelo-polymorphic proteins, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 197
Authors:
El Sayed, KA
Dunbar, C
Bartyzel, P
Zjawiony, JK
Day, W
Hamann, MT
Citation: Ka. El Sayed et al., Marine natural products as leads to develop new drugs and insecticides, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 233-252
Citation: Jd. Mcchesney, Commercialization of plant-derived natural products as pharmaceuticals: A view from the trenches, BIOLOGICALLY ACTIVE NATURAL PRODUCTS: PHARMACEUTICALS, 2000, pp. 253-264